DeepMed Research

Healthpoint

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1971-01-01

Employees: 501

Market Cap: -

Website: http://www.healthpointchc.org

Clinical Trials

Using Santyl or Bacitracin on Second Degree Burns

Phase 4

Withdrawn

Conditions: Burn, Partial Thickness

Interventions: Drug: Collagenase Santyl
Biological: Bacitracin

First Posted Date: 2012-01-24

Last Posted Date: 2012-05-16

Lead Sponsor: Healthpoint

Registration Number: NCT01516463

Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury

Phase 2

Terminated

Conditions: Pressure Ulcers
Spinal Cord Injury

Interventions: Drug: HP011-101 (Xenaderm Ointment)
Drug: Standard Care

First Posted Date: 2011-09-13

Last Posted Date: 2014-02-10

Lead Sponsor: Healthpoint

Target Recruit Count: 19

Registration Number: NCT01433159

Locations: 🇺🇸
James A. Haley Veterans Hospital, Tampa, Tampa, Florida, United States
🇺🇸
Kessler Institute for Rehabilitation, West Orange, New Jersey, United States
🇺🇸
VA Medical Center, Long Beach, Long Beach, California, United States

and more 2 locations

Using Santyl on Diabetic Foot Ulcers

Phase 4

Completed

Conditions: Diabetic Foot Ulcers
Diabetic Foot Wounds

Interventions: Biological: Santyl
Procedure: Control

First Posted Date: 2011-08-03

Last Posted Date: 2014-07-24

Lead Sponsor: Healthpoint

Target Recruit Count: 55

Registration Number: NCT01408277

Locations: 🇺🇸
Foot Healthcare Associates, PC, Southfield, Michigan, United States
🇺🇸
Robert Wunderlich, San Antonio, Texas, United States
🇺🇸
Endeavor Clinical Trials, San Antonio, Texas, United States

and more 4 locations

Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients

Phase 2

Completed

Conditions: Non-melanoma Skin Cancer

Interventions: Biological: HP802-247
Biological: Bacitracin Ointment

First Posted Date: 2011-05-25

Last Posted Date: 2017-06-29

Lead Sponsor: Healthpoint

Target Recruit Count: 8

Registration Number: NCT01359735

Locations: 🇺🇸
Derm Research PLC, Louisville, Kentucky, United States

HP011-101, HP828-101, and Standard Care for Pressure Ulcers

Phase 2

Withdrawn

Conditions: Pressure Ulcers

Interventions: Device: HP-828-101
Drug: HP011-101
Other: Standard Care

First Posted Date: 2011-01-10

Last Posted Date: 2012-09-12

Lead Sponsor: Healthpoint

Registration Number: NCT01273428

Study to Determine if Fibrin Affects the Ability of a Wound to Heal

Phase 1

Completed

Conditions: Effect of Test Articles on the Healing of a Wound Artificially Induced by Liquid Nitrogen Spray

Interventions: Biological: Fibrin
Other: White Petrolatum

First Posted Date: 2010-12-03

Last Posted Date: 2015-12-21

Lead Sponsor: Healthpoint

Target Recruit Count: 40

Registration Number: NCT01253135

Locations: 🇺🇸
Dept of Dermatology, University of Miami, Miami., Florida, United States

Wound Edge Changes Following Treatment With Santyl

Phase 4

Completed

Conditions: Diabetic Foot Ulcers
Diabetic Foot Wounds

Interventions: Other: Placebo Comparator
Biological: Collagenase Santyl Ointment

First Posted Date: 2010-09-09

Last Posted Date: 2013-05-30

Lead Sponsor: Healthpoint

Target Recruit Count: 10

Registration Number: NCT01197898

Locations: 🇺🇸
Associated Foot and Ankle Specialists, Phoenix, Arizona, United States

Study of Survival Duration for Donor Skin Cells in Skin Biopsy Wounds

Phase 1

Completed

Conditions: Normal Female Volunteers

Interventions: Biological: HP802-247

First Posted Date: 2010-08-30

Last Posted Date: 2017-07-02

Lead Sponsor: Healthpoint

Target Recruit Count: 28

Registration Number: NCT01190865

Locations: 🇺🇸
RCTS, Inc., Irving, Texas, United States

A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot Ulcers

Phase 4

Completed

Conditions: Diabetic Foot Ulcers

Interventions: Drug: Santyl
Other: White Petrolatum

First Posted Date: 2010-06-14

Last Posted Date: 2013-05-06

Lead Sponsor: Healthpoint

Target Recruit Count: 57

Registration Number: NCT01143714

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
🇺🇸
The Foot and Ankle Institute of Western Pennsylvania, Pittsburgh, Pennsylvania, United States
🇺🇸
Boston Medical Center, Boston, Massachusetts, United States

and more 3 locations

Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers

Phase 4

Completed

Conditions: Diabetic Foot Ulcers

Interventions: Drug: Tegaderm Hydrogel
Drug: Santyl

First Posted Date: 2010-06-14

Last Posted Date: 2013-05-31

Lead Sponsor: Healthpoint

Target Recruit Count: 20

Registration Number: NCT01143727

Locations: 🇺🇸
Richard C. Galperin, DPM, Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy